Literature DB >> 5294180

Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.

D M Mel, A L Terzin, L Vuksić.   

Abstract

In May 1963 a live vaccine prepared from streptomycin-dependent Shigella flexneri 2a was administered to 355 soldiers stationed in an area of Yugoslavia in which bacillary dysentery was hyperendemic. Five oral doses were given every third day. 382 unvaccinated soldiers from the same unit served as controls. Both groups were closely followed up until 16 September.Examination of 1637 rectal swabs from the vaccinated and control groups indicated that vaccination did not affect the carrier rate. The morbidity from shigellae of serotypes not contained in the vaccine was the same in the two groups; but Sh. flexneri 2a caused dysentery in 5.5% of the control group but in none of the vaccinated soldiers-a statistically significant difference.A similar vaccine, given in a much lower dose, was also tried among soldiers of another unit; the dose was insufficient to confer protection.The authors conclude that the results of these field trials justify further studies with live Shigella vaccine.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5294180      PMCID: PMC2555247     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection.

Authors:  D M Mel; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

2.  Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials.

Authors:  D M Mel; R G Papo; A L Terzin; L Vuksić
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

  2 in total
  33 in total

1.  Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium.

Authors:  P J Sansonetti; J Arondel; J R Cantey; M C Prévost; M Huerre
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

Review 3.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

4.  Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Authors:  K L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; M M Levine
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  The current status of shigellosis in the United States.

Authors:  E R Eichner; E J Gangarosa; J B Goldsby
Journal:  Am J Public Health Nations Health       Date:  1968-04

6.  Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.

Authors:  D F Keren; H H Collins; L S Baron; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.

Authors:  S B Formal; T L Hale; C Kapfer; J P Cogan; P J Snoy; R Chung; M E Wingfield; B L Elisberg; L S Baron
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Attenuated recombinant strains of Vibrio cholerae for oral immunization.

Authors:  B S Srivastava; V B Sinha; R Srivastava
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

9.  Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.

Authors:  D Mel; E J Gangarosa; M L Radovanovic; B L Arsic; S Litvinjenko
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

10.  Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.

Authors:  C Y Chu; B K Liu; D Watson; S S Szu; D Bryla; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.